Detalhe da pesquisa
1.
Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database.
J Cardiovasc Electrophysiol
; 30(7): 1066-1077, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30938894
2.
Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences.
BMC Health Serv Res
; 17(1): 74, 2017 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28114939
3.
The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis.
Eur J Prev Cardiol
; 24(17): 1843-1850, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28925748
4.
Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence.
Clin Ther
; 38(3): 478-93.e1-16, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26922297
5.
Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.
Perit Dial Int
; 34(7): 749-57, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25292402
6.
Inclusion of compliance and persistence in economic models: past, present and future.
Appl Health Econ Health Policy
; 10(6): 365-79, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23030640